MedPath

An ancillary study of "a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer(UMIN000027435)" - investigation of effect prediction bio-marker for adjuvant therapy.

Not Applicable
Conditions
on-small-cell lung cancer
Registration Number
JPRN-UMIN000027436
Lead Sponsor
Clinical Research Support Center Kyushu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
190
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing particular

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
/Protein expression analysis using immunohistochemical staining /Gene mutation analysis of tumor tissue specimen /Gene polymorphism analysis of tumor tissue specimen
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath